Back to Search Start Over

USP28 Deficiency Promotes Breast and Liver Carcinogenesis as well as Tumor Angiogenesis in a HIF-independent Manner

Authors :
Elitsa Y. Dimova
Teija Paakkola
Risto Kerkelä
Thomas Kietzmann
Hanna-Riikka Teppo
Zoltan Szabo
Anja Konzack
Risto Bloigu
Kateryna Kubaichuk
Arja Jukkola-Vuorinen
Heidi Ali-Kippari
Kati Richter
Daniela Mennerich
Kirsi-Maria Haapasaari
Nina Kozlova
Peppi Koivunen
Source :
Molecular Cancer Research. 16:1000-1012
Publication Year :
2018
Publisher :
American Association for Cancer Research (AACR), 2018.

Abstract

Recent studies suggest that the ubiquitin-specific protease USP28 plays an important role in cellular repair and tissue remodeling, which implies that it has a direct role in carcinogenesis. The carcinogenic potential of USP28 was investigated in a comprehensive manner using patients, animal models, and cell culture. The findings demonstrate that overexpression of USP28 correlates with a better survival in patients with invasive ductal breast carcinoma. Mouse xenograft experiments with USP28-deficient breast cancer cells also support this view. Furthermore, lack of USP28 promotes a more malignant state of breast cancer cells, indicated by an epithelial-to-mesenchymal (EMT) transition, elevated proliferation, migration, and angiogenesis as well as a decreased adhesion. In addition to breast cancer, lack of USP28 in mice promoted an earlier onset and a more severe tumor formation in a chemical-induced liver cancer model. Mechanistically, the angio- and carcinogenic processes driven by the lack of USP28 appeared to be independent of HIF-1α, p53, and 53BP1. Implications: The findings of this study are not limited to one particular type of cancer but are rather applicable for carcinogenesis in a more general manner. The obtained data support the view that USP28 is involved in tumor suppression and has the potential to be a prognostic marker. Mol Cancer Res; 16(6); 1000–12. ©2018 AACR.

Details

ISSN :
15573125 and 15417786
Volume :
16
Database :
OpenAIRE
Journal :
Molecular Cancer Research
Accession number :
edsair.doi.dedup.....c5283c20d37a94964b27a3e4986856b9